Overview Financials News + Filings Key Docs Charts Ownership Insiders |
Evolus, Inc. (EOLS)
|
Add to portfolio |
|
|
Price: |
$6.59
| | Metrics |
OS: |
57.0
|
M
| |
|
|
Market cap: |
$375
|
M
| |
-252
|
% ROIC
|
Net debt:
|
$53.1
|
M
| |
|
|
EV:
|
$429
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
($44.9)
|
M
| |
|
|
EBIT
|
($49.3)
|
M
| |
|
|
EPS |
($1.18)
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
Revenues | 148.6 | 99.7 | 56.5 | 34.9 | 0.0 | 0.0 | 12.6 | 20.7 |
Revenue growth | 49.1% | 76.3% | 61.9% | | | -100.0% | -39.0% | |
Cost of goods sold | 55.9 | 43.5 | 18.3 | 8.0 | 0.0 | 0.0 | 12.6 | 20.7 |
Gross profit | 92.7 | 56.1 | 38.2 | 26.9 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross margin | 62.4% | 56.3% | 67.6% | 77.1% | | | 0.0% | 0.0% |
Selling, general and administrative | 141.8 | 112.1 | 98.2 | 113.6 | 29.1 | | | |
Research and development | 4.7 | 2.1 | 1.7 | 4.0 | 6.5 | 6.7 | | |
General and administrative | | | | | | 4.8 | 7.0 | 9.9 |
EBITA | -54.2 | -58.3 | -65.1 | -90.9 | -46.1 | -11.7 | -20.0 | -31.0 |
EBITA margin | -36.5% | -58.5% | -115.1% | -260.4% | | | -158.4% | -149.8% |
Amortization of intangibles | 3.4 | 5.3 | 3.6 | 3.9 | | | | |
EBIT | -57.6 | -63.6 | -68.7 | -94.8 | -46.1 | -11.7 | -20.0 | -31.0 |
EBIT margin | -38.7% | -63.8% | -121.5% | -271.4% | | | -158.4% | -149.8% |
Pre-tax income | -74.3 | -46.8 | -162.9 | -105.1 | -46.8 | -11.7 | -20.0 | -31.0 |
Income taxes | 0.1 | 0.0 | 0.1 | -15.0 | 0.1 | -7.3 | 0.1 | 0.1 |
Tax rate | | | | 14.3% | | 61.8% | | |
Net income | -74.4 | -46.8 | -163.0 | -90.0 | -46.9 | -4.5 | 0.0 | 0.0 |
Net margin | -50.1% | -47.0% | -288.3% | -257.8% | | | 0.0% | 0.0% |
|
Diluted EPS | ($1.33) | ($0.94) | ($4.83) | ($3.19) | ($1.92) | ($0.27) | $0.00 | $0.00 |
Shares outstanding (diluted) | 56.1 | 49.8 | 33.7 | 28.2 | 24.4 | 16.5 | 16,527.0 | 16,527.0 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|